Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
55 | 29629 | 35.3 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CANDIDA ALBICANS | authKW | 1350590 | 8% | 54% | 2453 |
2 | CANDIDA | authKW | 823897 | 5% | 57% | 1415 |
3 | ASPERGILLOSIS | authKW | 538413 | 3% | 59% | 892 |
4 | AMPHOTERICIN B | authKW | 509720 | 3% | 52% | 963 |
5 | FLUCONAZOLE | authKW | 441420 | 3% | 53% | 811 |
6 | CANDIDEMIA | authKW | 403241 | 2% | 88% | 445 |
7 | MYCOSES | journal | 381368 | 4% | 35% | 1053 |
8 | VORICONAZOLE | authKW | 380173 | 2% | 60% | 618 |
9 | CANDIDIASIS | authKW | 379447 | 2% | 62% | 597 |
10 | ECHINOCANDINS | authKW | 366857 | 1% | 89% | 402 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Mycology | 329759 | 14% | 8% | 4026 |
2 | Microbiology | 196610 | 34% | 2% | 10190 |
3 | Infectious Diseases | 141369 | 21% | 2% | 6213 |
4 | Immunology | 19443 | 14% | 1% | 4094 |
5 | Pharmacology & Pharmacy | 18409 | 17% | 1% | 4938 |
6 | Dermatology | 9573 | 5% | 1% | 1426 |
7 | Dentistry, Oral Surgery & Medicine | 4473 | 4% | 1% | 1073 |
8 | Transplantation | 1759 | 2% | 0% | 594 |
9 | Respiratory System | 1758 | 3% | 0% | 777 |
10 | Medicine, General & Internal | 1313 | 5% | 0% | 1440 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ABERDEEN FUNGAL GRP | 96825 | 0% | 67% | 141 |
2 | IMMUNOCOMPROMISED HOST SECT | 96061 | 0% | 64% | 146 |
3 | MED MYCOL | 74983 | 1% | 22% | 327 |
4 | MYCOL REFERENCE | 64165 | 0% | 50% | 126 |
5 | MYCOT DIS BRANCH | 57264 | 0% | 44% | 127 |
6 | MICROBIAL PATHOGEN MECH | 55354 | 0% | 77% | 70 |
7 | ASPERGILLOSIS | 53696 | 0% | 83% | 63 |
8 | SERV MICOL | 51587 | 0% | 50% | 101 |
9 | INFECT DIS | 51199 | 7% | 3% | 2007 |
10 | MYCOL | 45017 | 1% | 15% | 291 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MYCOSES | 381368 | 4% | 35% | 1053 |
2 | MEDICAL MYCOLOGY | 250966 | 2% | 34% | 718 |
3 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 119147 | 6% | 7% | 1667 |
4 | JOURNAL DE MYCOLOGIE MEDICALE | 84790 | 1% | 31% | 269 |
5 | JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY | 75484 | 1% | 31% | 234 |
6 | MYCOPATHOLOGIA | 72988 | 2% | 14% | 506 |
7 | EUKARYOTIC CELL | 51339 | 1% | 15% | 347 |
8 | REVISTA IBEROAMERICANA DE MICOLOGIA | 50425 | 0% | 36% | 136 |
9 | JOURNAL OF CLINICAL MICROBIOLOGY | 49814 | 4% | 4% | 1149 |
10 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 34481 | 2% | 5% | 656 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CANDIDA ALBICANS | 1350590 | 8% | 54% | 2453 | Search CANDIDA+ALBICANS | Search CANDIDA+ALBICANS |
2 | CANDIDA | 823897 | 5% | 57% | 1415 | Search CANDIDA | Search CANDIDA |
3 | ASPERGILLOSIS | 538413 | 3% | 59% | 892 | Search ASPERGILLOSIS | Search ASPERGILLOSIS |
4 | AMPHOTERICIN B | 509720 | 3% | 52% | 963 | Search AMPHOTERICIN+B | Search AMPHOTERICIN+B |
5 | FLUCONAZOLE | 441420 | 3% | 53% | 811 | Search FLUCONAZOLE | Search FLUCONAZOLE |
6 | CANDIDEMIA | 403241 | 2% | 88% | 445 | Search CANDIDEMIA | Search CANDIDEMIA |
7 | VORICONAZOLE | 380173 | 2% | 60% | 618 | Search VORICONAZOLE | Search VORICONAZOLE |
8 | CANDIDIASIS | 379447 | 2% | 62% | 597 | Search CANDIDIASIS | Search CANDIDIASIS |
9 | ECHINOCANDINS | 366857 | 1% | 89% | 402 | Search ECHINOCANDINS | Search ECHINOCANDINS |
10 | CASPOFUNGIN | 329151 | 1% | 86% | 371 | Search CASPOFUNGIN | Search CASPOFUNGIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PAPPAS, PG , KAUFFMAN, CA , ANDES, DR , CLANCY, CJ , MARR, KA , OSTROSKY-ZEICHNER, L , REBOLI, AC , SCHUSTER, MG , VAZQUEZ, JA , WALSH, TJ , ET AL (2016) CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF CANDIDIASIS: 2016 UPDATE BY THE INFECTIOUS DISEASES SOCIETY OF AMERICA.CLINICAL INFECTIOUS DISEASES. VOL. 62. ISSUE 4. P. E1 -E50 | 392 | 77% | 59 |
2 | PATTERSON, TF , THOMPSON, GR , DENNING, DW , FISHMAN, JA , HADLEY, S , HERBRECHT, R , KONTOYIANNIS, DP , MARR, KA , MORRISON, VA , NGUYEN, MH , ET AL (2016) PRACTICE GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF ASPERGILLOSIS: 2016 UPDATE BY THE INFECTIOUS DISEASES SOCIETY OF AMERICA.CLINICAL INFECTIOUS DISEASES. VOL. 63. ISSUE 4. P. E1 -E60 | 472 | 79% | 17 |
3 | PFALLER, MA , DIEKEMA, DJ , (2007) EPIDEMIOLOGY OF INVASIVE CANDIDIASIS: A PERSISTENT PUBLIC HEALTH PROBLEM.CLINICAL MICROBIOLOGY REVIEWS. VOL. 20. ISSUE 1. P. 133-+ | 261 | 91% | 1605 |
4 | LATGE, JP , (1999) ASPERGILLUS FUMIGATUS AND ASPERGILLOSIS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 12. ISSUE 2. P. 310 -+ | 485 | 81% | 1113 |
5 | POLKE, M , HUBE, B , JACOBSEN, ID , (2015) CANDIDA SURVIVAL STRATEGIES.ADVANCES IN APPLIED MICROBIOLOGY, VOL 91. VOL. 91. ISSUE . P. 139 -235 | 466 | 80% | 12 |
6 | PAPPAS, PG , KAUFFMAN, CA , ANDES, D , BENJAMIN, DK , CALANDRA, TF , EDWARDS, JE , FILLER, SG , FISHER, JF , KULLBERG, BJ , OSTROSKY-ZEICHNER, L , ET AL (2009) CLINICAL PRACTICE GUIDELINES FOR THE MANAGEMENT OF CANDIDIASIS: 2009 UPDATE BY THE INFECTIOUS DISEASES SOCIETY OF AMERICA.CLINICAL INFECTIOUS DISEASES. VOL. 48. ISSUE 5. P. 503 -535 | 210 | 84% | 1338 |
7 | GONCALVES, SS , SOUZA, ACR , CHOWDHARY, A , MEIS, JF , COLOMBO, AL , (2016) EPIDEMIOLOGY AND MOLECULAR MECHANISMS OF ANTIFUNGAL RESISTANCE IN CANDIDA AND ASPERGILLUS.MYCOSES. VOL. 59. ISSUE 4. P. 198 -219 | 290 | 96% | 5 |
8 | WALSH, TJ , ANAISSIE, EJ , DENNING, DW , HERBRECHT, R , KONTOYIANNIS, DP , MARR, KA , MORRISON, VA , SEGAL, BH , STEINBACH, WJ , STEVENS, DA , ET AL (2008) TREATMENT OF ASPERGILLOSIS: CLINICAL PRACTICE GUIDELINES OF THE INFECTIOUS DISEASES SOCIETY OF AMERICA.CLINICAL INFECTIOUS DISEASES. VOL. 46. ISSUE 3. P. 327 -360 | 217 | 81% | 1096 |
9 | SHAPIRO, RS , ROBBINS, N , COWEN, LE , (2011) REGULATORY CIRCUITRY GOVERNING FUNGAL DEVELOPMENT, DRUG RESISTANCE, AND DISEASE.MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS. VOL. 75. ISSUE 2. P. 213 -267 | 424 | 68% | 107 |
10 | AMBASTA, A , CARSON, J , CHURCH, DL , (2015) THE USE OF BIOMARKERS AND MOLECULAR METHODS FOR THE EARLIER DIAGNOSIS OF INVASIVE ASPERGILLOSIS IN IMMUNOCOMPROMISED PATIENTS.MEDICAL MYCOLOGY. VOL. 53. ISSUE 6. P. 531 -557 | 250 | 92% | 5 |
Classes with closest relation at Level 2 |